Product Information
VERAPAMIL ER PM 300 MG CAPSULE is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $7.9598 per EA under NDC 52536048737. Its NADAC has been published 46 times since Oct 8, 2025.
FDA first approved this application on Nov 25, 1998.
Strength
300 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536048737
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020943FDA Approved
11/25/1998
On Market Since
11/26/2024
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER PM 300 MG CAPSULE has been published 46 times since Oct 8, 2025, and over the history we have for it it has risen 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.9598 per EA |
|---|---|
| All-time high | $8.0429 (May 13, 2026) |
| All-time low | $7.5962 (Oct 8, 2025) |
| 52-week high | $8.0429 |
| 52-week low | $7.5962 |
| Median price | $7.8963 |
| Average price | $7.8312 |
| Largest weekly change | +2.3% (Feb 18, 2026) |
| Weeks tracked | 46 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VERAPAMIL ER PM 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER PM 300 MG CAPSULE, manufactured by Wilshire Pharmaceuticals Inc., is $7.9598 per EA (NDC 52536048737), effective Aug 19, 2026.
How has the price of VERAPAMIL ER PM 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER PM 300 MG CAPSULE has risen 4.8%. It has been tracked across 46 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER PM 300 MG CAPSULE?
Since Oct 8, 2025, the NADAC for VERAPAMIL ER PM 300 MG CAPSULE has ranged from a low of $7.5962 (Oct 8, 2025) to a high of $8.0429 (May 13, 2026), with a median of $7.8963 per EA.
Are there cheaper alternatives to VERAPAMIL ER PM 300 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VERAPAMIL ER PM 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures VERAPAMIL ER PM 300 MG CAPSULE?
VERAPAMIL ER PM 300 MG CAPSULE (NDC 52536048737) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.